Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma. - Rawson RV; Maher NG; Menzies AM; Lo SN; Mesbah Ardakani N; Jackett LA; Vergara IA; Pennington TE; Shannon KF; Ch'ng S; Gonzalez M; Burton EM; et al. (Annals of oncology : official journal of the European Society for Medical Oncology, 2026)